8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001479290-21-000097
CIK 0001479290operating
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:05 PM ET
Size
179.1 KB
Accession
0001479290-21-000097
Documents
- 8-Krvnc-20210406.htmPrimary
8-K
- EX-101.SCHrvnc-20210406.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.CALrvnc-20210406_cal.xml
XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
- EX-101.DEFrvnc-20210406_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
- EX-101.LABrvnc-20210406_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErvnc-20210406_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLrvnc-20210406_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001479290-21-000097-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:05 PM ET
- Size
- 179.1 KB